CONSUMERS BANCORP, INC. financials

CBKM CIK 0001006830

Source: EDGAR filings · Built 2026-06-19T00:37:25Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 4.86M 8.39M 11.49M 13.47M 12.86M 5.10M
Net Margin 186.47% 195.76% 257.89% 289.65% 263.19% 171.86%
Return on Equity (ROE) 11.36% 13.47% 19.24% 20.74% 12.86% 8.74%
Return on Assets (ROA) 0.74% 0.78% 1.01% 1.15% 1.08% 0.75%
Debt-to-Equity 0.21× 0.48× 0.48× 0.39× 0.17× 0.11×
Effective Tax Rate 16.05% 17.70% 17.40% 17.29% 17.07% 14.16%
Cash Conversion Ratio 0.92× 1.09× 1.25× 1.34× 1.56× 1.01×
Accruals Ratio 0.00× -0.00× -0.00× -0.00× -0.01× -0.00×
CapEx Coverage 2.58× 9.54× 7.31× 10.12× 12.14× 11.25×
Free Cash Flow Per Share $1.55 $2.70 $3.72 $4.43 $4.26 $1.77

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Income Tax Expense (Benefit) 1.66M 1.84M 2.25M 2.34M 1.85M 912.00K
Net Income (Loss) Attributable to Parent 8.67M 8.58M 10.67M 11.19M 8.99M 5.53M
Earnings Per Share, Basic $2.77 $2.76 $3.45 $3.68 $2.98 $1.92
Weighted Average Number of Shares Outstanding, Basic 3.13M 3.11M 3.09M 3.04M 3.02M 2.87M
Earnings Per Share, Diluted $2.77 $2.76 $3.45 $3.68 $2.98 $1.92
Weighted Average Number of Shares Outstanding, Diluted 3.13M 3.11M 3.09M 3.04M 3.02M 2.87M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Assets 1.17B 1.10B 1.06B 977.31M 833.80M 740.82M
Liabilities 1.09B 1.03B 1.00B 923.34M 763.90M 677.58M
Stockholders' Equity Attributable to Parent 76.27M 63.69M 55.48M 53.97M 69.90M 63.24M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 7.93M 9.38M 13.32M 14.95M 14.01M 5.59M
Payments to Acquire Property, Plant, and Equipment 3.07M 983.00K 1.82M 1.48M 1.15M 497.00K
Net Cash Provided by (Used in) Investing Activities -61.70M -30.45M -92.22M -65.22M -89.00M -113.05M
Net Cash Provided by (Used in) Financing Activities 55.95M 27.04M 69.71M 52.70M 83.86M 107.66M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (CBKM CIK 0001006830), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

BLMN

BLOOMIN’ BRANDS, INC.

IPHYF

Innate Pharma SA

SFD

SMITHFIELD FOODS, INC.